BioTrace Medical Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

BioTrace Medical General Information

Description

Developer of a cardiac pacing device designed to treat reversible symptomatic bradycardia. The company's device lead delivers secure and stable pacing, reducing complications and allowing patients to ambulate sooner after procedures like cardiac surgery, enabling healthcare providers to improve the lives of the patients and cure them.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 1600 West Merit Parkway
  • South Jordan, UT 84095
  • United States
+1 (800)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Parent Company
Corporate Office
  • 1600 West Merit Parkway
  • South Jordan, UT 84095
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioTrace Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 31-Oct-2022 Completed Generating Revenue
6. Later Stage VC (Series B2) 15-Mar-2021 Completed Generating Revenue
5. Debt - PPP 12-Apr-2020 Completed Generating Revenue
4. Later Stage VC 23-Jan-2019 Completed Generating Revenue
3. Early Stage VC (Series B) 30-Jun-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 15-Jun-2015 $1.8M $5.3M Completed Generating Revenue
1. Early Stage VC (Series A) 24-Feb-2014 $3.5M $3.5M Completed Generating Revenue
To view BioTrace Medical’s complete valuation and funding history, request access »

BioTrace Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B
Series A 3,953,693 $0.001000 $0.19 $1.35 $1.35 1x $1.35 23.46%
To view BioTrace Medical’s complete cap table history, request access »

BioTrace Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cardiac pacing device designed to treat reversible symptomatic bradycardia. The company's device lead del
Therapeutic Devices
South Jordan, UT
19 As of 2022

Eindhoven, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioTrace Medical Competitors (1)

One of BioTrace Medical’s competitors is Xeltis, a Venture Capital-Backed company based in Eindhoven, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Xeltis Venture Capital-Backed Eindhoven, Netherlands
You’re viewing 1 of 1 competitors. Get the full list »

BioTrace Medical Patents

BioTrace Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021080765-A1 Devices and methods for retention of temporary pacing leads Inactive 21-Oct-2019
WO-2015172023-A2 Device and method for positioning an electrode in a body cavity Inactive 09-May-2014
WO-2015172023-A3 Device and method for positioning an electrode in a body cavity Inactive 09-May-2014
JP-2020054850-A Device and method for positioning electrode in body cavity Active 09-May-2014
JP-2022084906-A Devices and methods for placing electrodes in the body cavity Active 09-May-2014 A61N1/0558
To view BioTrace Medical’s complete patent history, request access »

BioTrace Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioTrace Medical Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arrize Capital Venture Capital Minority
Cambrian Growth Partners Growth/Expansion Minority
Edwards Lifesciences Corporation Minority
Emergent Medical Partners Venture Capital Minority
Fogarty Innovation Accelerator/Incubator Minority
You’re viewing 5 of 11 investors. Get the full list »

BioTrace Medical FAQs

  • When was BioTrace Medical founded?

    BioTrace Medical was founded in 2013.

  • Where is BioTrace Medical headquartered?

    BioTrace Medical is headquartered in South Jordan, UT.

  • What is the size of BioTrace Medical?

    BioTrace Medical has 19 total employees.

  • What industry is BioTrace Medical in?

    BioTrace Medical’s primary industry is Therapeutic Devices.

  • Is BioTrace Medical a private or public company?

    BioTrace Medical is a Private company.

  • What is BioTrace Medical’s current revenue?

    The current revenue for BioTrace Medical is .

  • How much funding has BioTrace Medical raised over time?

    BioTrace Medical has raised $22.2M.

  • Who are BioTrace Medical’s investors?

    Arrize Capital, Cambrian Growth Partners, Edwards Lifesciences, Emergent Medical Partners, and Fogarty Innovation are 5 of 11 investors who have invested in BioTrace Medical.

  • Who are BioTrace Medical’s competitors?

    Xeltis is a competitor of BioTrace Medical.

  • When was BioTrace Medical acquired?

    BioTrace Medical was acquired on 31-Oct-2022.

  • Who acquired BioTrace Medical?

    BioTrace Medical was acquired by Merit Medical Systems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process